# The &#8216;Psychedelic&#8217; Claims of THC-O-Acetate Debunked

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/the-psychedelic-claims-of-thc-o-acetate-debunked/
> **Published:** 2023-07-11T19:02:22-04:00 | **Last Modified / Clinically Audited:** 2026-05-29T10:13:36-04:00
> **Clinical Summary:** In the dynamic world of cannabis, THC-O-acetate has recently emerged as the new player on the field, largely due to bold claims of it providing a &#8216;psychedelic&#8217; experience. But what does the science actually say? A new study led by UB has delved into these claims and found that the effects of THC-O-acetate are more [&hellip;]

---

In the dynamic world of cannabis, THC-O-acetate has recently emerged as the new player on the field, largely due to bold claims of it providing a ‘psychedelic’ experience. But what does the science actually say?

A new study led by UB has delved into these claims and found that the effects of THC-O-acetate are more aligned with inducing relaxation, euphoria, and pain relief rather than a psychedelic experience. This contradicts the current narrative floating around the cannabis community.

Moreover, the study raises an important point of concern. The [cannabis market](https://cedclinic.com/im-cannabis-revenue-report-c-54-7m-positive-cash-flow/), as it currently stands, is largely unregulated. This can result in product contamination, potentially causing unexpected and undesirable effects. Hence, it emphasizes the importance of being cautious in this seemingly Wild West market.

As consumers, it’s crucial to be vigilant and rely more on scientific evidence rather than simply accepting manufacturer claims. In the rapidly expanding world of cannabinoids, safety should always be paramount. Dive deeper into the study here: [https://bit.ly/46KsuEv](https://bit.ly/46KsuEv)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
